Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2026-01-25 @ 7:59 AM
Study NCT ID:
NCT03535259
Status:
COMPLETED
Last Update Posted:
2024-01-10
First Post:
2018-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma
Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hepatocellular Carcinoma, Radiotherapy, Sorafenib | View |